Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers AR Parikh, I Leshchiner, L Elagina, L Goyal, C Levovitz, G Siravegna, ... Nature medicine 25 (9), 1415-1421, 2019 | 417 | 2019 |
The lens capsule BP Danysh, MK Duncan Experimental eye research 88 (2), 151-164, 2009 | 339 | 2009 |
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma NJ Haradhvala, MB Leick, K Maurer, SH Gohil, RC Larson, N Yao, ... Nature medicine 28 (9), 1848-1859, 2022 | 112 | 2022 |
Parallel genomic alterations of antigen and payload targets mediate polyclonal acquired clinical resistance to sacituzumab govitecan in triple-negative breast cancer JT Coates, S Sun, I Leshchiner, N Thimmiah, EE Martin, D McLoughlin, ... Cancer discovery 11 (10), 2436-2445, 2021 | 88 | 2021 |
Abnormal expression of collagen IV in lens activates unfolded protein response resulting in cataract Z Firtina, BP Danysh, X Bai, DB Gould, T Kobayashi, MK Duncan Journal of Biological Chemistry 284 (51), 35872-35884, 2009 | 87 | 2009 |
BRAF inhibitors: experience in thyroid cancer and general review of toxicity ME Cabanillas, A Patel, BP Danysh, R Dadu, S Kopetz, G Falchook Hormones and Cancer 6, 21-36, 2015 | 72 | 2015 |
Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma model BP Danysh, EY Rieger, DK Sinha, CV Evers, GJ Cote, ME Cabanillas, ... Oncotarget 7 (21), 30907, 2016 | 66 | 2016 |
AXL and error-prone DNA replication confer drug resistance and offer strategies to treat EGFR-mutant lung cancer A Noronha, N Belugali Nataraj, JS Lee, B Zhitomirsky, Y Oren, S Oster, ... Cancer discovery 12 (11), 2666-2683, 2022 | 52 | 2022 |
Characterizing molecular diffusion in the lens capsule BP Danysh, TP Patel, KJ Czymmek, DA Edwards, L Wang, J Pande, ... Matrix Biology 29 (3), 228-236, 2010 | 48 | 2010 |
Improved cellular specificity of plasmonic nanobubbles versus nanoparticles in heterogeneous cell systems EY Lukianova-Hleb, X Ren, PE Constantinou, BP Danysh, DL Shenefelt, ... Plos one 7 (4), e34537, 2012 | 47 | 2012 |
Src-mediated regulation of the PI3K pathway in advanced papillary and anaplastic thyroid cancer TC Beadnell, KW Nassar, MM Rose, EG Clark, BP Danysh, MC Hofmann, ... Oncogenesis 7 (2), 23, 2018 | 46 | 2018 |
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome EM Parry, I Leshchiner, R Guièze, C Johnson, E Tausch, SA Parikh, ... Nature medicine 29 (1), 158-169, 2023 | 40 | 2023 |
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance A Naeem, F Utro, Q Wang, J Cha, M Vihinen, S Martindale, Y Zhou, Y Ren, ... Blood advances 7 (9), 1929-1943, 2023 | 37 | 2023 |
The transcription factor ETV5 mediates BRAFV600E-induced proliferation and TWIST1 expression in papillary thyroid cancer cells OR Puli, BP Danysh, E McBeath, DK Sinha, NM Hoang, RT Powell, ... Neoplasia 20 (11), 1121-1134, 2018 | 35 | 2018 |
Contributions of mouse genetic background and age on anterior lens capsule thickness BP Danysh, KJ Czymmek, PT Olurin, JG Sivak, MK Duncan The Anatomical Record: Advances in Integrative Anatomy and Evolutionary …, 2008 | 35 | 2008 |
Transmembrane mucins as novel therapeutic targets PE Constantinou, BP Danysh, N Dharmaraj, DD Carson Expert review of endocrinology & metabolism 6 (6), 835-848, 2011 | 33 | 2011 |
Ponatinib activates an inflammatory response in endothelial cells via ERK5 SUMOylation J Paez-Mayorga, AL Chen, S Kotla, Y Tao, RJ Abe, ED He, BP Danysh, ... Frontiers in cardiovascular medicine 5, 125, 2018 | 27 | 2018 |
Parallel genomic alterations of antigen and payload targets mediate polyclonal acquired clinical resistance to sacituzumab govitecan in triple-negative breast cancer. Cancer … JT Coates, S Sun, I Leshchiner, N Thimmiah, EE Martin, D McLoughlin, ... DOI: https://doi. org/10.1158/2159-8290. CD-21-0702, 2436-2445, 0 | 21 | |
RAC1 Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient R Bagheri-Yarmand, NL Busaidy, E McBeath, BP Danysh, KW Evans, ... Cancers 13 (19), 4950, 2021 | 20 | 2021 |
The MUC1 ectodomain: a novel and efficient target for gold nanoparticle clustering and vapor nanobubble generation BP Danysh, PE Constantinou, EY Lukianova-Hleb, DO Lapotko, ... Theranostics 2 (8), 777, 2012 | 20 | 2012 |